From this list of candidate markers, we tested ATOH1 and TFAP2B as potential new IHC markers for MCC and carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) as a novel marker for SCLC. This evidence concerns the gene TFAP2B and Merkel cell skin cancer.